Mind + Muscle

technical minds + legal muscle


dig deep

Modern Bio/Pharma Patent Prosecution Strategies

  • 09.15.17
  • 1:30 p.m.

This panel will discuss patent prosecution strategies for your bio/pharma innovations, including the following:

  • An update on best practices for drafting and prosecuting patent applications in light of generics, biosimilars, and post-grant challenges
  • The increased prevalence of inherent obviousness rejections at the USPTO
  • Effective project management and communication between outside and in-house counsel

Panel Moderator: Eric K. Steffe, Director

Panelist: Paul A. Calvo, Ph.D., Director

Panelist: Marsha Rose Gillentine, Ph.D., Director

Panelist: Andy Brookes, Section Head, IP Strategy, AbbVie

Panelist: Danielle Pasqualone, Ph.D., J.D., Executive Director, Intellectual Property, Five Prime Therapeutics, Inc.

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.